CrossRef

Changes in therapeutic response, ocular manifestations of Graves’ orbitopathy and quality of life during the first year after orbital radiotherapy

International Ophthalmology 43(11) (2023)

Mariya Asenova Stoynova; Alexander Dimitrov Shinkov; Miroslav Todorov Novoselski; Victoria Vladimirova Petrova; Inna Dimitrova Dimitrova; Inna Angelova Yankova; Roussanka Dimitrova Kovatcheva

Early Low‐Dose Rituximab for Mild‐to‐Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety

International Journal of Endocrinology 2026(1) (2026)

Ming Lu; Luqiang Wang; Xuelian Zhang; Suraiya Saleem

A novel treatment for malignant spasticity: The therapeutic use of stereotactic radiosurgery (SRS)

Radiotherapy and Oncology 169 (2022)

Luca Nicosia; Elena Rossato; Renato Avesani; Fabio Marchioretto; Giuseppe Armani; Massimo Zamperini; Giovanni Foti; Fatemeh Jafari; Antonio De Simone; Ruggero Ruggieri; Filippo Alongi; Federico Ferrari

Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy

Current Neurology and Neuroscience Reports 22(6) (2022)

Tracy J. Lu; Linus Amarikwa; Connie M. Sears; Andrea L. Kossler

Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review

Endocrine 85(2) (2024)

Martina Verrienti; Irene Gagliardi; Luisa Valente; Antonio Stefanelli; Luca Borgatti; Elena Franco; Manlio Galiè; Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio

Untitled

No retinopathy after orbital irradiation in patients with thyroid eye disease – a follow up study

Frontiers in Endocrinology 16 (2025)

Sara Makhoul; Janos K. Aranyosi; Emese Csiki; Hilda Urbancsek; Edit B. Nagy; Annamaria Erdei; Mariann Fodor; Arpad Kovacs; Endre V. Nagy; Bernadett Ujhelyi